Is a complete TPEX/1784 research report available?

No complete published report is available for tpex/1784 (TPEX/1784) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

tpex/1784 stock profile: metrics, valuation and analysis

Market cap	2.9B
Revenue (ttm)	1.3B
Net income (ttm)	57.2M
EPS (ttm)	NT$1.14
Shares out	49.8M
P/E (trailing)	51.3x
Dividend	NT$0.87 (1.44%)
Volume	40,714
Beta	0.57

All TPEX/1784 indicators

Market & fundamental data

Available fields

250

Groups with data

Currency

TWD

Showing 250 of 250 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Enterprise value	TWD 2.6B
Exchange	Taipei Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Diagnostics & Research
Isin	TW0001784007
Last refreshed	2026-09-12
Market cap	TWD 2.9B
Price	TWD 58.4
Price currency	TWD
Sector	Healthcare
Sector PE	87.76
Sector PE Fwd	27.81
Sic	2836
Symbol	tpex/1784
Website	https://www.bionetcorp.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.96%
EV Earnings	44.84x
EV/EBITDA	50.73x
EV/FCF	33.38x
EV/Sales	1.98x
FCF yield	2.64%
P/B ratio	1.32x
P/E ratio	51.33x
P/S ratio	2.25x
PE Ratio10 Y	114.55x
PE Ratio3 Y	62.53x
PE Ratio5 Y	65.33x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-1.22%
EBITDA Margin	2.81%
FCF margin	5.93%
Gross margin	55.8%
Gross Profit	TWD 722.3M
Gross Profit Growth	4.96%
Gross Profit Growth Q	15.73%
Gross Profit Growth3 Y	5.51%
Gross Profit Growth5 Y	8.7%
Net Income	TWD 57.2M
Net Income Growth	-19.63%
Net Income Growth Q	73.57%
Net Income Growth Qo Q	60.05%
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Net Income Growth3 Y	-10.92%
Net Income Growth5 Y	12.78%
Pretax Margin	1.66%
Profit Margin	4.42%
Profitable Quarters	TWD 15
Profitable Years	7
ROA	-0.32
Roa5y	1.35
ROCE	-0.6
ROE	0.37
Roe5y	3.07
ROIC	-0.7
Roic5y	3.88

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	8.23%
Cagr15y	4.03%
Cagr1y	-31.33%
Cagr20y	7.43%
Cagr3y	0.54%
Cagr5y	7.43%
Div CAGR10	8.58%
Div CAGR3	10.65%
Div CAGR5	38.56%
EPS Growth	-18.76
EPS Growth Q	72.88
EPS Growth Qo Q	58.58
EPS Growth Quarters	2
EPS Growth Years	0
EPS Growth3 Y	-10.7
EPS Growth5 Y	13.08
FCF Growth	26.47%
FCF Growth Q	-14.88%
FCF Growth3 Y	-7.29%
FCF Growth5 Y	34%
OCF Growth	3.77%
OCF Growth Q	-28.62%
OCF Growth Qo Q	1,249.78%
OCF Growth3 Y	13.6%
OCF Growth5 Y	36.53%
Revenue Growth	5.41x
Revenue Growth Q	11.15x
Revenue Growth Qo Q	7.52x
Revenue Growth Quarters	3x
Revenue Growth Years	6x
Revenue Growth3 Y	6.83x
Revenue Growth5 Y	7.44x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0.42
Assets	TWD 3.1B
Cash	TWD 1.5B
Current Assets	TWD 1.9B
Current Liabilities	TWD 450.1M
Debt	TWD 140.4M
Debt EBITDA	TWD 2.78
Debt Equity	TWD 0.06
Debt FCF	TWD 1.83
Equity	TWD 2.2B
Interest Coverage	-6.47
Liabilities	TWD 879.3M
Long Term Assets	TWD 1.2B
Long Term Liabilities	TWD 429.2M
Net Cash	TWD 1.3B
Net Cash By Market Cap	TWD 45.35
Net Cash Growth	-8.48%
Net Debt EBITDA	TWD -36.26
Net Debt Equity	TWD -0.6
Net Debt FCF	TWD -17.18
Tangible Book Value	TWD 1.2B
Tangible Book Value Per Share	TWD 24.04
WACC	7.05

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.27
Inventory Turnover	5.68
Net Working Capital	TWD 123M
Quick ratio	3.93
Working Capital	TWD 1.5B
Working Capital Turnover	TWD 0.88

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.97%
Dividend Growth	-37.8%
Dividend Growth Years	5%
Dividend per share	TWD 0.87
Dividend Years	8
Dividend Yield	1.44%
Ex Div Date	2026-10-01
Last Dividend	TWD 0.88
Payout Frequency	Annual
Payout Ratio	122.54%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	120.51%
1Y total return	-31.31%
200-day SMA	80.59
3Y total return	1.62%
50-day SMA	61.52
50-day SMA vs 200-day SMA	50under200
5Y total return	43.09%
All Time High	201.1
All Time High Change	-70.96%
All Time High Date	2007-07-26
All Time Low	13.26
All Time Low Change	340.49%
All Time Low Date	2004-09-17
ATR	1.34
Beta	0.57
Beta1y	0.75
Beta2y	0.84
Ch YTD	-43.57
High	59
High52	118
High52 Date	2026-01-14
High52ch	-50.51%
Low	58.4
Low52	54
Low52 Date	2026-07-29
Low52ch	8.15%
Ma50ch	-5.07%
Price vs 200-day SMA	-27.53%
RSI	39.06
RSI Monthly	40.07
RSI Weekly	33.79
Sharpe ratio	-0.49x
Sharpe Ratio3y	0.12x
Sharpe Ratio5y	0.34x
Sortino ratio	-0.63
Sortino Ratio3y	0.32
Sortino Ratio5y	0.67
Total Return	2.42%
Tr YTD	-43.57
Tr15y	80.95%
Tr1m	-5.5%
Tr1w	-1.35%
Tr3m	-11.92%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	39,390,897%
Net Borrowing	86,179,000
Shares Insiders	5.49%
Shares Institutions	1.77%
Shares Out	49,830,000
Shares Qo Q	-0.32%
Shares Yo Y	-0.97%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TWD 55M
Adjusted OCF	147,277,000
Average Volume	64,157.25x
Bv Per Share	24.63
CAPEX	TWD -92.3M
Ch10y	107.8
Ch15y	55.19
Ch1m	-5.5
Ch1w	-1.35
Ch1y	-32.49
Ch20y	230.9
Ch3m	-11.92
Ch3y	-0.73
Ch5y	36.7
Ch6m	-34.09
Change	-1.02%
Change From Open	-0.85
Close	59
Days Gap	-0.17
Depreciation Amortization	52,206,000
Dollar Volume	2,377,697.6
Earnings Date	2026-11-12
EBIT	TWD -15.8M
EBITDA	TWD 36.4M
EPS	TWD 1.14
F Score	4
FCF	TWD 76.8M
FCF EV Yield	3x
FCF Per Share	TWD 1.54
Financing CF	-69,759,000
Fiscal Year End	December
Founded	1,989
Goodwill	10,091,000
Graham Number	25.11301
Graham Upside	-57
Income Tax	TWD 13.1M
Investing CF	-89,367,000
Is Primary Listing	1
Last Earnings Date	2025-11-11
Last Report Date	2026-06-30
Last Split Date	2024-09-19
Last Split Type	Forward
Lynch Fair Value	TWD 14.55
Lynch Upside	-75.09
Ma150	73.22
Ma150ch	-20.24%
Ma20	60.66
Ma20ch	-3.72%
Net CF	10,243,000
Next Earnings Date	2026-11-12
Open	58.9
P FCF Ratio	37.89
P FCF Ratio SBC	52.95
P OCF Ratio	17.21
P OCF Ratio SBC	19.76
Payment Date	2026-10-30
Position In Range	0
Ppne	678,525,000
Price Date	2026-09-11
Price EBITDA	TWD 79.94
Ptbv Ratio	2.43
Relative Volume	0.6x
Revenue	1,294,448,000x
SBC By Revenue	1.69x
Share Based Comp	21,844,000
Tax By Revenue	1.01x
Tax Rate	61.04%
Tr20y	319.06%
Tr6m	-34.09%
Volume	40,714
Z Score	3.96

TPEX/1784 (TPEX/1784)

Price

Financial snapshot

Fair-value bridge

Latest news · TPEX/1784

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TPEX/1784 indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on TPEX/1784

Frequently asked questions